Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection

Table 3

Multivariate analysis of risk factors affecting development of adenomatous polyps in H. pylori-positive patients.

Multivariate analysis
	Crude OR	CI		Adjusted OR	CI
Age ≥ 50	3.13	1.81	5.65	2.76	1.59	4.77
Sex	1.83	1.19	2.81	1.79	1.17	2.73
Triple therapy	0.52	0.34	0.801	0.69	0.44	1.07
Chronic PPI use	0.484	0.31	0.76	0.69	0.43	1.09
Triple therapy and; chronic PPI use	0.36	0.22	0.78	0.26	0.10	0.646